Gene Lee was quoted in "PTAB Petition Fall Tied to Broad Litigation Trends," an article in Managing Intellectual Property, regarding the decrease in petitions to the U.S. Patent Trial and Appeal Board.

Perkins Coie is pleased to announce that its Intellectual Property practice has been recognized as a 2019 Practice Group of the Year by Law360. In its annual assessment of leading law firm practice groups, Law360 recognizes the firms that won significant litigation victories and managed large deals.

Perkins Coie has earned a spot among Law360's 2019 Intellectual Property Group of the Year.

Partner Nate Kelley was quoted in the Law360 article, "Patent Cases To Watch In 2020," regarding the U.S. Supreme Court possible decision to address the contentious issue of patent eligibility, and the justices guidelines on appeals of inter partes review decisions.

Partner Nate Kelley was quoted in the Law360 article, "Patent Litigation Trends To Watch In 2020," regarding the trend of emboldened patent owners driving up infringement cases at U.S. district courts.

Perkins Coie is pleased to announce that the firm and ten partners were recognized as leaders in inter partes review (“IPR”) in Patexia’s 2019 IPR Intelligence Report, an annual comprehensive report of IPR data and analysis over the last five years.

Nate Kelley was quoted in The National Law Journal article, "Patent Lawsuits Up in 2019; PTAB Filings Down," regarding PTAB's increasing reluctance to hold trials on patent validity challenges.

Perkins Coie is pleased to announce that the firm and 33 of its intellectual property attorneys were recognized by Intellectual Asset Management in the IAM Patent 1000 list for 2019, which recognizes the world’s leading patent professionals who are the best in class in patent prosecution, licensing and litigation.

Partner Gene Lee was mentioned in the Law360 article, "PTAB Axes 2 Card Game Patents Under Alice," regarding his representation of Bally when the Patent Trial and Appeal Board invalidated two card game patents at the center of a licensing dispute between Bally and another casino game maker.

Perkins Coie is pleased to announce that the firm and 26 of its intellectual property attorneys were recognized in Managing Intellectual Property’s (MIP) 2019 IP Stars list. Additionally, two women partners, Shannon Bloodworth, Firmwide Co-Chair of the Intellectual Property practice, and Grace Han Stanton again landed on the MIP Top 250 Women in IP list.

Brandon White was quoted in the Law360 article, "The Do's and Don'ts of Extra Discovery at the PTAB," regarding how to handle the discovery process with the Patent Trial and Appeal Board.

Perkins Coie is pleased to announce that Gene Lee, a partner in the firm’s Patent Litigation practice, was appointed to the New York Intellectual Property Law Association’s (NYIPLA) Board of Directors at the 2019 Annual Meeting held on May 14, 2019.

Nate Kelley was mentioned in multiple publications regarding the U.S. Court of Appeals for the Federal Circuit's ruling to uphold the U.S. Patent Trial and Appeal Board decision to invalidate a patent on Johnson & Johnson's prostate cancer drug, Zytiga.

Perkins Coie is pleased to announce that it has been ranked nationally in every area of intellectual property by Managing IP in its 2019 IP Stars rankings, including patent litigation, post-grant proceedings and patent prosecution. 

Perkins Coie is pleased to announce that it was named as having a patent impact case of the year by Managing IP’s Americas Awards for the successful representation of Mylan in its industry-shaping win in Saint Regis Mohawk Tribe v. Mylan Pharmaceuticals Inc., which convinced the U.S. Court of Appeals for the Federal Circuit that Indian tribal sovereign immunity cannot block the Patent Trial and Appeal Board (PTAB) from undertaking inter partes reviews (IPRs).

Perkins Coie is pleased to announce that it has been recognized by Law360 as one of the firms that “crushed it” in patent cases decided by the Federal Circuit in 2018. 

Perkins Coie is pleased to announce that the firm has been recognized as one of the top four patent litigation defense law firms in the nation by Docket Navigator in its 2018 “Patent Litigation Year in Review” report. Of the national law firms handling the most patent defense cases, Perkins Coie ranked fourth. The firm also ranked as the ninth most active firm representing both patent owners and petitioners in post-grant proceedings.

Perkins Coie is pleased to announce that the firm has been recognized as one of the top four patent litigation defense law firms in the nation by Lex Machina in its annual “Patent Litigation Year in Review” report. Of the national law firms handling the most patent defense cases in 2018, Perkins Coie ranked fourth, with 51 cases across 28 jurisdictions. In its handling of defense cases, the firm ranked second in terms of the most number of districts in which firms appeared. Perkins Coie also ranked as the fifth most active national firm representing petitioners in post-grant proceedings.

Nathan Kelley was mentioned in multiple publications regarding his joining the firm's Intellectual Property practice in the Washington, D.C. office.

Perkins Coie was recently named to the Honor Roll of the inaugural Inclusion Blueprint Survey, a joint initiative between ChIPs, a nonprofit organization focused on advancing women in technology, law and policy, and diversity and inclusion incubator, Diversity Lab.

Perkins Coie is pleased to announce that Nathan Kelley has joined the firm’s highly recognized Intellectual Property practice as a partner in the Washington, D.C. office. Kelley recently stepped down as the Solicitor and Deputy General Counsel for Intellectual Property Law at the U.S. Patent and Trademark Office (USPTO). Kelley earlier acted as the USPTO’s Chief Administrative Patent Judge in charge of the Patent Trial and Appeal Board (PTAB).

Perkins Coie was mentioned in the Big Law Business article, "New Survey Rates Big Law Policies to Build Gender Equality," for scoring in the Top 10 of firms making the largest strides in closing the gender gap in the workplace.

Perkins Coie was mentioned in The Recorder article, "New ChIPs-Backed Survey Seeks Gender Parity in Intellectual Property Practices," for being one of the highest-ranking performers in a new survey conducted by nonprofit ChIPs and the Diversity Lab.

Perkins Coie is one of the top seven firms that general counsel look to hire for IP Litigation, according to the 2019 BTI Litigation Outlook report, an annual analysis by BTI Consulting Group of the legal landscape. 

David Anstaett, Shannon Bloodworth, Brandon White, Dan Bagatell, and Christina Jordan McCullough were mentioned in the Law360* article, "Fed. Circ. Rules Teva's Copaxone Patents Are Invalid," as representation for Mylan Pharmaceuticals Inc. Bloomberg also covered the decision in the article, "Teva Loses Appeal Over Four Patents for MS Drug Copaxone."
*Subscription-based publication

Perkins Coie represented Mylan in its recent milestone Federal Circuit wins, relating to Glatiramer Acetate Injection 40mg/mL. The decision was reported in the Mylan article, "Mylan Prevails in Copaxone® 40mg/mL Litigation Against Teva in U.S. Appellate Court."

Perkins Coie is proud to announce the launch of 1600 PTAB & Beyond, a blog that reports from the intersection of the life sciences industry and key decisions and developments from the Patent Trial and Appeal Board (PTAB), district courts and appellate courts.

Perkins Coie was noted as counsel to Mylan, Teva and Akorn in the Law.com article, "Skilled in the Art: The Brave New World of Section 101 Guidance," which discusses whether Native American tribal immunity protects patents from inter partes review.

Perkins Coie attorney Brandon White was noted as counsel to Mylan in the Law360 article, “Allergan, Tribe Fight PTAB's Immunity Denial at Fed. Circ.,” regarding The Patent Trial and Appeal Board going against decades of U.S. Supreme Court precedent.

Michael Wise was recognized by the Daily Journal as a "Top Intellectual Property Attorney in California." In the article, "Michael J. Wise," he was quoted regarding his recent success.  

Gene Lee was featured as the newly elected Patent Trial and Appeal Board Association director.

Perkins Coie is pleased to announce that Gene W. Lee, a partner in the firm’s Patent Litigation practice, has been elected as a Director of the Patent Trial and Appeal Board (PTAB) Bar Association at its Annual Conference in Washington, D.C. on Thursday, March 22, 2018.

The Perkins Coie team representing Mylan was mentioned in the Law360 article, “Tribe Asks Fed. Circ. To Pause Restasis Patent Reviews,” regarding the Federal Circuit being asked to stop the Patent Trial and Appeal Board’s review of certain patents.

Michelle Umberger was quoted in the Technology Transfer Tactics article, "Fully Leverage Licensing, Faculty Resources to Pick Up on Potential Infringement," regarding due diligence, licensing and obtaining legal advice.

Perkins Coie is pleased to announce that the firm has been recognized by Law360 as one of the firms that “dominated” in patent cases decided by the Federal Circuit in 2017 due to its 8–1 win–loss record. Perkins Coie tied for fifth in total victories, and the firm’s record tied for second-best of all listed firms. This is the second year in a row that Perkins Coie has been ranked in the top eight for overall case wins.

Perkins Coie is pleased to announce that the firm has been recognized as one of the top three patent litigation defense law firms in the nation by Lex Machina in its fourth annual Patent Litigation Year in Review report. Of the national law firms handling the most patent cases in 2017, Perkins Coie ranked third with 56 of those cases. This is the second year in a row Perkins Coie has been in the top three.

Perkins Coie is pleased to announce that Steve Bishop and Shannon Bloodworth have been named Firmwide Co-Chairs of the firm’s Intellectual Property practice. Steve, a partner in the firm’s Seattle office, and Shannon, a partner in its Washington, D.C. office, succeed former Co-Chairs Paul Parker and Jon James.

Perkins Coie is pleased to announce that the firm’s Patent Prosecution Platform, “P4,” was recognized as the most innovative initiative in the Business of Law: Technology category as part of the 2017 Financial Times North American Innovative Lawyers Report.

On November 9, 2017, Perkins Coie LLP hosted a patent law seminar program at the Senmao Conference Center in Shanghai. The seminar addressed a variety of pressing intellectual property (IP) issues facing Chinese companies with business interests in the United States.

On November 8, 2017, Perkins Coie LLP, along with the China Chamber of International Commerce (CCOIC) and the Zhonglun W&D Law Firm, hosted a program titled “Sino-U.S. Trade and Investment: New Regulations, Policies and Practices” at the Beijing Capital Club. Chinese and U.S. attorneys, senior officers and executives came together to explore the current state of some of the key regulatory, legal and practical issues of Sino-U.S. trade and investment.

On November 7, 2017, Perkins Coie LLP hosted a patent law seminar at the Oriental Bay International Hotel in Beijing. The seminar addressed current intellectual property (IP) legal issues facing Chinese companies and enterprises whose products are sold in the United States.

On November 2, 2017, Perkins Coie LLP, along with the Shenzhen Patent Association (SZPA), presented a seminar on timely and critical legal issues impacting international manufacturers who export or sell products and do business in the United States.

On October 31, 2017, Perkins Coie LLP, along with the Chinese National Federation of Industries (CNFI), presented a thoughtful and timely discussion of key legal issues impacting international manufacturers who sell products and do business in the United States.

Perkins Coie is pleased to announce that the firm has been recognized as one of the top ten post-grant law firms in the nation by Lex Machina in its second annual review of Patent Trial and Appeal Board (PTAB) proceedings.

Perkins Coie is proud to announce that 252 of its attorneys were selected by their peers for inclusion in the 2017 edition of The Best Lawyers In America®, the oldest and most respected peer-review publication in the legal profession.

Perkins Coie was recently named the sixth ranked firm in the country for the number of Patent Trial and Appeal Board (PTAB) proceedings handled, with 71 overall PTAB matters, according to Docket Navigator’s 2015 Year in Review.

In its Final Written Decision, the Board determined that Petitioner had shown that all challenged claims of the ’888 Patent are unpatentable. The ’888 Patent discloses an audio recording device that the specification terms a “music jukebox.”  Read more.

In its Final Written Decision, the Board found that Petitioner had shown by a preponderance of the evidence that all challenged claims of the ’403 patent are unpatentable.  Read more. 

Perkins Coie is proud to announce that 245 of its attorneys were selected by their peers for inclusion in the 2016 edition of The Best Lawyers In America®, the oldest and most respected peer-review publication in the legal profession; a more than 10 percent increase over the 221 firm attorneys recognized by Best Lawyers in the 2015 edition.

The America Invents Act created new administrative trials for litigating patent invalidity issues before the USPTO's Patent Trial and Appeal Board by inter partes review. IPR trials can be initiated by any person who is not the patent owner and not otherwise barred from filing an IPR petition on a given patent.

Perkins Coie is pleased to announce that 30 of the firm’s intellectual property attorneys were recognized by Intellectual Asset Management (IAM) in the IAM Strategy 300 and IAM Patent 1000 lists.